Skip to main content
. 2006 May 15;148(5):648–656. doi: 10.1038/sj.bjp.0706761

Figure 7.

Figure 7

Effects of butyrate or chol-but SLN effects on FMLP-evoked myeloperoxidase release by PMNs. The results are expressed as percentage inhibition of myeloperoxidase release evoked by 10−8M FMLP in the absence of butyrate or chol-but SLN: this release was 31±5%. Data are expressed as means±s.e.m.; n=5 Asterisks mark statistically significant inhibition of chol-but SLN versus butyrate (*P<0.01).